The mode of action of paracetamol (acetaminophen), which is widely used for treating pain and fever, has remained obscure, but may involve several distinct mechanisms, including cyclooxygenase inhibition and transient receptor potential ankyrin 1 (TRPA1) channel activation, the latter being recently associated with paracetamol's propensity to elicit hypothermia at higher doses. Here we examined if the antipyretic effect of paracetamol was due to TRPA1 activation or cyclooxygenase inhibition. Treatment of wild-type and TRPA1
Introduction
Paracetamol (acetaminophen) is one of the most commonly used over-the-counter drugs to treat pain and fever. However, its mechanism of action has remained a matter of discussion.
Similar to nonsteroidal anti-inflammatory drugs (NSAIDs), paracetamol has been shown to inhibit prostaglandin synthesis (1, 2) , but has been suggested to do so not by interfering with the active site of prostaglandin synthesizing cyclooxygenases, as done by NSAIDs, but by reducing their active oxidized form to their resting form (3) . Paracetamol mediated cyclooxygenase inhibition would therefore be more effective under conditions of low peroxide concentration, such as in the brain, but inactive under conditions of high peroxidase concentrations, such as in an inflammatory site. Such a mechanism would be consistent with the known tissue selectivity of acetaminophen and explain why it is antipyretic and antinociceptive while possessing only minor anti-inflammatory properties (3, 4) .
During recent years, the idea that paracetamol exerts its action by cyclooxygenase inhibition has been challenged. It has been shown that the anti-nociceptive effect of paracetamol may be executed by the formation of paracetamol metabolites, such as the Nacylphenolamine derivative N-arachidonoylaminophenol (AM404) and N-acetyl-pbenzoquinoneimine (NAPQI) activating the TRP ion channels transient receptor potential vanilloid 1 (TRPV1) and transient receptor potential ankyrin 1 (TRPA1), respectively (5) (6) (7) (8) .
Paracetamol given at a high dose is known to induce hypothermia both in mice and humans (9) , and it was recently demonstrated that this effect is dependent on TRPA1 but not on TRPV1 (10) . In the same study it was also reported that the same high dose of paracetamol that produced hypothermia in wild-type (WT) mice normalized body temperature in TRPA1 knock-out (KO) mice in a model of yeast induced fever, suggesting that paracetamol produces antipyretic and hypothermic effects through distinct and independent mechanisms (10).
Here we examined the antipyretic effect of paracetamol, using a well-established lipopolysaccharide (LPS)-induced fever paradigm (11) (12) (13) . We titrated a dose of paracetamol that does not produce hypothermia when given to WT mice, and after having verified that paracetamol-induced hypothermia is TRPA1 mediated, we administered the sub-hypothermic dose to TRPA1 KO and WT mice that had been rendered febrile by peripheral injection of bacterial cell wall lipopolysaccharide. We report that paracetamol exerts an antipyretic effect in both genotypes, i.e. it is independent of TRPA1, and we show that the antipyretic effect is associated with cyclooxygenase inhibition and normalized prostaglandin E2 levels in the brain. Furthermore, we show that the glutathione precursor N-acetyl cysteine protects WT mice from the hypothermic effect of paracetamol, indicating that the paracetamol-induced hypothermia, similar to what was shown for its analgesic effect in some experimental paradigms, is mediated by the activation of TRPA1 by paracetamol's electrophilic metabolites, such as NAPQI (5) .
Materials and Methods

Animals
Adult TRPA1 KO and WT mice of both sexes were used, and experimental groups were balanced with respect to sex and age. The KO mice were originally provided by Dr. David Julius (14) (RRID: MGI:3696956) and backcrossed for over 10 generations onto C57BL/6 mice (Taconic, Denmark) in the laboratory of Högestätt and Zygmunt. Homozygous breeding was then used for 2-3 generations to create KO and WT mice for experiments. The mice were kept at a 12:12 h light/dark cycle (light on at 7.00 a.m.) with free access to food and water.
All injections were given early during the light period. Between and after injections animals were left undisturbed to avoid eliciting activity related temperature responses. All experiments were approved by the Linköping and Lund Animal Ethics Committees, and were in accordance with the European Union directive for the use of animals for scientific purposes (2010/63).
Drugs
In the experiments monitoring body temperature, LPS from Escherichia coli (100 µg/kg; Sigma, St. Louis, MO, USA; 0111:B4), paracetamol (100-200 mg/kg; Sigma), and parecoxib (10 mg/kg, Dynastat®; Pfizer, Sollentuna, Sweden) were all diluted in saline and injected intraperitoneally (i.p.; ~ 0.1 ml). N-acetyl cysteine (1g/kg; Meda, Solna, Sweden) was diluted in saline and injected subcutaneously (s.c.; ~0.3 ml).
Telemetric temperature recordings
The mice were briefly anesthetized with 1 % isoflurane (Abbot Scandinavia, Solna, Sweden) and implanted i.p. with a transmitter that records core body temperature (Data Sciences International, New Brighton, MN, USA; model TA11TAF10). Buprenorphine (Temgesic; 100 µg/kg, in about 0.1 ml saline i.p.; RB Pharmaceuticals, Sough, Berkshire, UK) was given for post-operative analgesia. Immediately after the surgery, the mice were transferred to a room in which the ambient temperature was set to 29°C, providing near-thermoneutral conditions (13) . The animals were allowed to recover for at least 1 week before any recordings were made. This time period was selected to permit e.g. the replenishment of cytochrome P450 2E1 (CYP2E1), the liver enzyme which metabolizes paracetamol to its electrophilic metabolite NAPQI, which activates TRPA1 (5), and which is known to be inhibited by isoflurane and other fluorinated anesthetics (15) . Prior to drug injection, the basal temperature of each mouse was recorded for at least 24 h to assure that they displayed normal body temperature with normal circadian variation. All statistical analyses were done in Graph Pad Prism (GraphPad Software, La Jolla, CA, USA).
Mass spectrometry analyses of prostanoids
LPS
Results
TRPA1 KO mice display normal circadian temperature variation
We monitored basal temperature of WT and TRPA1 KO mice during a 48-h period. Both WT and TRPA1 KO mice showed normal circadian temperature rhythm, and there was no significant difference between the genotypes (Fig. 1) . However, for both genotypes, female mice displayed a slightly higher average temperature than male mice (37.4°C vs 36.8°C for WT mice, and 37.3°C vs 36.8 for KO mice).
Paracetamol given at 200 mg/kg, but not at 150 mg/kg, produces TRPA1-dependent hypothermia
We titrated a dose of the paracetamol that did not produce hypothermia. We found that 200 mg/kg body weight injected i.p. to WT mice resulted in pronounced hypothermia, whereas 100 and 150 mg/kg did not (1-way ANOVA: F3,14 = 9.292, P = 0.0012 at nadir temperature; P = 0.0153 for 200 mg vs 150 mg paracetamol; Fig. 2A, A1 ). This observation is consistent with that previously reported by Li et al. (16) , who found that 160 mg/kg paracetamol produced hypothermia, whereas doses <160 mg/kg did not. It is also in line with the observation by Gentry et al. (10) that 300 mg/kg, but not 100 mg/kg produced hypothermia.
We then verified that the hypothermia induced by the higher dose of paracetamol (200 mg/kg) indeed was TRPA1 mediated. We found that whereas WT mice displayed hypothermia, as in the previous experiment ( Fig. 2A) , the body temperature of TRPA1 KO 
N-acetyl cysteine abolishes paracetamol induced hypothermia
Because the analgesic effect of paracetamol may be mediated by the binding to TRPA1 of its electrophilic metabolites, such as NAPQI (5), we examined if NAPQI also was involved in paracetamol induced hypothermia. We therefore treated WT mice with N-acetyl cysteine (NAC), which replenishes the glutathione needed for metabolizing NAPQI into an inactive conjugate (17). We found that mice treated with 1g/kg NAC, given s. 
TRPA1 KO mice display LPS induced fever, similar to WT mice, and in both genotypes 150 mg/kg paracetamol is antipyretic
Having established that a dose of 150 mg/kg paracetamol did not produce hypothermia in non-immune challenged mice, we used this dose, known to produce analgesia (7, 18) the first injection; Fig. 3A) . Similarly, mice of both genotypes that first had been injected with LPS and as a second injection received saline showed a stress induced increase of their body temperature, but from an already elevated level (Fig. 3A) . Importantly, mice first injected with LPS and which in a second injection was given paracetamol displayed a prominent but transient temperature fall, which for TRPA1 KO mice normalized their body temperature [2-way ANOVA (treatment): F1,36 = 54.47 and P < 0.0001; P < 0.0001 and P = 0.0008 for paracetamol vs NaCl treatment of WT and KO mice respectively], hence demonstrating that TRPA1 is not necessary for the antipyretic effect of paracetamol (Fig. 3A,   A2 ). In WT mice, however, paracetamol not only normalized the body temperature, but . There was no statistically significant difference between male and female mice, with WT mice of both sexes displaying hypothermia after paracetamol, whereas neither male or female KO mice did so.
To determine if the different sensitivity to 150 mg/kg paracetamol between febrile WT and TRPA1 KO mice was dependent on paracetamol induced activation of TRPA1, we repeated the experiment with antipyretic treatment of LPS-induced fever, but this time with the cyclooxygenase-2 (Cox-2) inhibitor parecoxib, for which no interaction with TRPA1
should be expected. Injection of parecoxib 4 h after LPS resulted in a temperature depression that was almost identical in magnitude between TRPA1 KO and WT mice (Fig. 3B) ,
suggesting that the differences seen between genotypes in the response to paracetamol were TRPA1 dependent.
Based on these observations we hypothesized that the increased sensitivity of febrile mice to the hypothermic effect of paracetamol was due to reduced glutathione stores and hence reduced capacity to neutralize paracetamol's electrophilic metabolites. We tested this hypothesis by treating febrile WT mice with the cysteine prodrug NAC, which replenishes the intracellular levels of the antioxidant glutathione, before they were injected with paracetamol. As shown in Fig. 3C , NAC strongly attenuated the paracetamol induced hypothermia.
Paracetamol inhibits LPS-induced prostanoid synthesis in the brain
Finally, we examined to what extent paracetamol inhibited prostanoid synthesis when given during LPS-induced fever. WT mice were injected with LPS followed by either paracetamol or vehicle 4 h later. A control group was given saline followed 4 h later by vehicle. Animals were killed 40 min after the last injection and brain and blood were collected for analysis.
This time point is about midway between Tmax for paracetamol (19) and nadir of its antipyretic effect (Fig. 3A, A2 ). In selecting this time point we reasoned that the most prominent suppression of prostaglandin levels in the brain (including the levels of PGE2)
would be seen prior to nadir of the temperature response when temperature still was falling rapidly, because at nadir, PGE2 levels should be rising to be able to reverse the temperature fall.
As shown in (Fig. 4E) ]. Paracetamol treatment also yielded very low TXB2 levels in blood (Fig.   4C) ; however, the differences vs the non-paracetamol treated groups were not statistically significant.
Discussion
The present findings show that a dose of paracetamol that does not elicit hypothermia when given to naïve mice, still has the capacity to normalize the body temperature of mice rendered febrile by peripheral injection of LPS. The abolishment of fever was seen both in WT mice and in TRPA1 KO mice, demonstrating that the antipyretic effect of paracetamol is not dependent on TRPA1. Furthermore, the antipyretic effect of paracetamol was temporally associated with a complete suppression of the increased PGE2 levels in the brain that was seen in mice given LPS but treated with vehicle instead of paracetamol. Because induced production of PGE2 is critical for fever (20-22), the present findings, taken together, indicate that paracetamol exerts its antipyretic effect by inhibiting prostaglandin synthesis, a mechanism that hence is different from the mechanism by which paracetamol, at high doses, evokes hypothermia (10) . The latter mechanism depends on TRPA1 and seems to involve paracetamol metabolites, such as NAPQI, because, as shown here, it is abolished by NAC, a substance that promotes inactivation of NAPQI. Hence, it is similar to the mechanism by which paracetamol is anti-nociceptive, which has been shown also to depend on TRPA1, at least in some experimental paradigms (5) .
The present study also shows that LPS-induced fever is independent of TRPA1 as LPS evoked the same temperature elevation in both WT and TRPA1 KO mice. In contrast, it has been shown that pain and acute vascular reactions caused by LPS are primarily dependent on TRPA1 activation in nociceptive sensory neurons (23) and that LPS-evoked mechanical hypersensitivity is dependent on TRPA1 via the endogenous activator hydrogen sulfide (24-
26). LPS-induced fever is attenuated by genetic deletion in brain endothelial cells of IL-6
receptors (12) and of prostaglandin synthesizing enzymes (27), implying a mechanism by which humorally released proinflammatory cytokines act on the brain, which is distinct from the mechanisms by which LPS elicits pain. These data are well in line with two distinct mode of actions by which paracetamol is antipyretic and anti-nociceptive, respectively.
We previously demonstrated that the antipyretic action of paracetamol was dependent on the gene dose of the prostaglandin synthesizing enzyme Cox-2. We showed that mice heterozygous for the Cox-2 gene, and hence displaying lower levels of Cox-2, were more sensitive to the fever reducing effect of paracetamol than WT mice (28). Specifically, we demonstrated that the largest paracetamol dose that had no effect on LPS induced fever in WT mice strongly attenuated fever in Cox-2 heterozygous mice, whereas no difference was seen between mice homozygous and heterozygous, respectively, for the terminal PGE2
isomerase microsomal prostaglandin E synthase-1 (mPGES-1), implying that paracetamol PGE2 levels also in non-immune challenged mice (7, 30, 31) , suggesting that it may act both on constitutive and inducible PGE2-production. Although the ability of paracetamol to reduce constitutive levels of PGE2 was not directly tested in the present study, it should be noted that the average PGE2 level after paracetamol treatment of mice rendered febrile by LPS injection was in fact lower than that seen in control mice that had been given two consecutive injections of saline and vehicle only (Fig. 4A) ; however, the difference was not statistically significant. Furthermore, the present data showing that paracetamol not only blocked induced PGE2, implying an effect on Cox-2, but also reduced the levels of other prostaglandins and TXB2 ( Fig. 4B-E ), indicate that paracetamol inhibits both Cox-1 and Cox-2. This idea is consistent with the hypothesis that paracetamol interacts with the peroxidase site of the cyclooxygenase enzymes (32), present in both isoforms. This effect would preferentially be seen in tissues with low peroxide concentration, such as the brain.
It should also be noted that there was no induction of PGE2 in blood, with PGE2 levels being under the detection limit in all examined treatment groups. Blood-borne PGE2, through diffusion or transport into the brain, has been suggested to be involved in immune-induced fever (33, 34). However, it is unlikely to play such a role at the time point (280 min post injection) examined in the present study.
Interestingly, there seems to be a critical dose between 150 mg/kg and 200 mg/kg for paracetamol-induced hypothermia in mice. Li et al. (16) defined the dose to 160 mg/kg, and in the present study 200 mg/kg yielded hypothermia, whereas 150 mg did not, and Gentry et al. (10) reported hypothermia (in WT but not in TRPA1 mice) when 300 mg/kg was given s.c., whereas 100 mg/kg (given intrathecally) had no effect on body temperature. We found that WT mice treated with 150 mg/kg paracetamol when having been rendered febrile by a previous injection of LPS, displayed hypothermia, whereas TRPA1 KO mice did not (Fig.   3A, A2 ). Since the same treatment with a selective Cox-2 inhibitor instead of paracetamol resulted in a normalized temperature in both TRPA1 KO and WT mice without eliciting hypothermia (Fig. 3B) , the findings indicated that paracetamol at the given dose indeed interacted with TRPA1. TRPA1 is a unique chemosensor strictly controlled by the redox status (35, 36). The reason for the increased sensitivity of the febrile mice to the hypothermic effect of paracetamol is therefore probably explained by reduced glutathione stores as a consequence of the oxidative stress associated with inflammation and fever (37) and hence reduced capacity to neutralize the TRPA1-binding of paracetamol's electrophilic metabolites.
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This idea was supported by the finding that the cysteine prodrug NAC, which replenishes the intracellular levels of the antioxidant glutathione and itself is a scavenger of tissue damaging thiol reactive agents such as NAPQI (17), strongly attenuated the hypothermia elicited by 150 mg/kg paracetamol in the febrile mice (Fig. 3C ).
In conclusion, we show that paracetamol exerts an antipyretic effect that is TRPA1-independent and that this effect is associated with inhibition of the synthesis of PGE2 (as well as of other prostanoids) in the brain. Taken together with previous findings, these data support evidence that paracetamol exerts its antipyretic effect by inhibiting cyclooxygenase enzymes. However, paracetamol also activates TRPA1 through its electrophilic metabolite NAPQI. This activation elicits hypothermia when paracetamol is given at high doses, but may also contribute to the antipyretic effect of lower paracetamol doses, especially during febrile conditions. Fig. 3A . The upper 4 traces (deep blue and light blue for WT mice, and magenta and pink for KO mice) seen between about 120 and 240 min represent mice that were given LPS, and the lower 4 traces (dark green and green for WT mice, and brown and yellow for KO mice) represent mice that instead were given saline. At about 300 min, the upper two traces (light blue and pink) represent LPS treated mice WT or KO, respectively, that were given saline at 240 min, whereas the deep blue and magenta traces represent LPS treated WT and KO mice that were given paracetamol at 240 min. Dark green, green, brown and yellow traces represent WT and KO animals that first were injected with saline (instead of LPS) and at 240 min given either paracetamol (dark green and brown) or saline (green and yellow). n = 10 for LPS treated mice and n = 3-4 for mice given saline instead of LPS.
